Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.
about
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@en
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@nl
type
label
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@en
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@nl
prefLabel
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@en
Combination of COX-2 expressio ...... ib treatment in breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Combination of COX-2 expressio ...... xib treatment in breast cancer
@en
P2093
Camille Benoist
Céline Callens
Florence Lerebours
Franck Assayag
Maud Kamal
Sophie Vacher
Véronique Becette
P2860
P304
85124-85141
P356
10.18632/ONCOTARGET.13200
P407
P577
2016-12-01T00:00:00Z